[HTML][HTML] Angiotensin-converting enzyme inhibitors induce cough
İ Yılmaz - Turkish thoracic journal, 2019 - ncbi.nlm.nih.gov
Turkish thoracic journal, 2019•ncbi.nlm.nih.gov
Angiotensin-converting enzyme inhibitors (ACE-I) are widely used in diseases, such as
hypertension, congestive heart failure, and myocardial infarction. Although these drugs are
well tolerated, one out of five patients discontinues ACE-I due to drug side effects, mainly
chronic cough. However, the pathogenesis of ACE-I-induced cough remains controversial
and requires further study. In this review, the mechanisms that are suggested in ACE-I-
induced cough pathophysiology will be discussed in detail in light of the current literature.
hypertension, congestive heart failure, and myocardial infarction. Although these drugs are
well tolerated, one out of five patients discontinues ACE-I due to drug side effects, mainly
chronic cough. However, the pathogenesis of ACE-I-induced cough remains controversial
and requires further study. In this review, the mechanisms that are suggested in ACE-I-
induced cough pathophysiology will be discussed in detail in light of the current literature.
Abstract
Angiotensin-converting enzyme inhibitors (ACE-I) are widely used in diseases, such as hypertension, congestive heart failure, and myocardial infarction. Although these drugs are well tolerated, one out of five patients discontinues ACE-I due to drug side effects, mainly chronic cough. However, the pathogenesis of ACE-I-induced cough remains controversial and requires further study. In this review, the mechanisms that are suggested in ACE-I-induced cough pathophysiology will be discussed in detail in light of the current literature.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果